• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一名毛里塔尼亚儿童因LRP5基因新突变导致骨质疏松-假性胶质瘤综合征

Osteoporosis-Pseudoglioma in a Mauritanian Child due to a Novel Mutation in LRP5.

作者信息

Biha Noura, Ghaber S M, Hacen M M, Collet Corinne

机构信息

Rheumatology Department, Nouakchott Military Hospital, Mauritania; Faculté de Médecine de Nouakchott, Mauritania.

Faculté de Médecine de Nouakchott, Mauritania; Service des Laboratoires, Centre Hospitalier National de Nouakchott, Mauritania.

出版信息

Case Rep Genet. 2016;2016:9814928. doi: 10.1155/2016/9814928. Epub 2016 Jan 19.

DOI:10.1155/2016/9814928
PMID:26904320
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4745298/
Abstract

Osteoporosis-pseudoglioma (OPPG) syndrome is a very rare autosomal recessive disorder, caused by mutations in the low-density lipoprotein receptor-related protein 5 (LRP5) gene. It manifests by severe juvenile osteoporosis with congenital or infancy-onset visual loss. We describe a case of OPPG due to novel mutation in LRP5 gene, occurring in a female Mauritanian child. This 10-year-old female child was born blind, and after then multiple fragility fractures appeared. PCR amplification and sequencing revealed a novel homozygous nonsense mutation in exon 10 of the LRP5 gene (c.2270G>A; pTrP757(⁎)); this mutation leads to the production of a truncated protein containing 757 amino acids instead of 1615, located in the third β-propeller domain of the LRP5 protein. Both parents were heterozygous for the mutation. This is the first case of the OPPG described in black Africans, which broadens the spectrum of LRP5 gene mutations in OPPG.

摘要

骨质疏松-假性胶质瘤(OPPG)综合征是一种非常罕见的常染色体隐性疾病,由低密度脂蛋白受体相关蛋白5(LRP5)基因突变引起。其表现为严重的青少年骨质疏松症,并伴有先天性或婴儿期开始的视力丧失。我们描述了一例因LRP5基因新突变导致的OPPG病例,该病例发生在一名毛里塔尼亚女童身上。这名10岁女童出生时失明,之后出现了多处脆性骨折。聚合酶链反应(PCR)扩增和测序显示,LRP5基因第10外显子存在一种新的纯合无义突变(c.2270G>A;pTrP757(⁎));该突变导致产生一种截短的蛋白质,包含757个氨基酸而非1615个氨基酸,位于LRP5蛋白的第三个β-螺旋桨结构域。父母双方均为该突变的杂合子。这是在非洲黑人中描述的首例OPPG病例,拓宽了OPPG中LRP5基因突变的范围。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb4/4745298/3f23c751126c/CRIG2016-9814928.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb4/4745298/d07ee2a2c5c5/CRIG2016-9814928.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb4/4745298/a67d0a296ad9/CRIG2016-9814928.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb4/4745298/4f930d5ca20f/CRIG2016-9814928.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb4/4745298/3f23c751126c/CRIG2016-9814928.004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb4/4745298/d07ee2a2c5c5/CRIG2016-9814928.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb4/4745298/a67d0a296ad9/CRIG2016-9814928.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb4/4745298/4f930d5ca20f/CRIG2016-9814928.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5fb4/4745298/3f23c751126c/CRIG2016-9814928.004.jpg

相似文献

1
Osteoporosis-Pseudoglioma in a Mauritanian Child due to a Novel Mutation in LRP5.一名毛里塔尼亚儿童因LRP5基因新突变导致骨质疏松-假性胶质瘤综合征
Case Rep Genet. 2016;2016:9814928. doi: 10.1155/2016/9814928. Epub 2016 Jan 19.
2
Osteoporosis-pseudoglioma syndrome: three novel mutations in the LRP5 gene and response to bisphosphonate treatment.骨质疏松-假瘤综合征:LRP5 基因中的三个新突变及双膦酸盐治疗的反应。
Horm Res Paediatr. 2012;77(2):115-20. doi: 10.1159/000336193. Epub 2012 Mar 23.
3
Novel Homozygous LRP5 Mutations in Mexican Patients with Osteoporosis-Pseudoglioma Syndrome.患有骨质疏松-假性神经胶质瘤综合征的墨西哥患者中的新型LRP5纯合突变
Genet Test Mol Biomarkers. 2017 Dec;21(12):742-746. doi: 10.1089/gtmb.2017.0118. Epub 2017 Nov 13.
4
Novel LRP5 gene mutation in a patient with osteoporosis-pseudoglioma syndrome.患者骨质疏松-假性脑肿瘤综合征中存在 LRP5 基因突变。
Joint Bone Spine. 2010 Mar;77(2):151-3. doi: 10.1016/j.jbspin.2009.11.013. Epub 2010 Jan 21.
5
Osteoporosis-pseudoglioma syndrome: clinical, genetic, and treatment-response study of 10 new cases in Greece.骨质疏松-假瘤综合征:希腊 10 例新病例的临床、遗传和治疗反应研究。
Eur J Pediatr. 2019 Mar;178(3):323-329. doi: 10.1007/s00431-018-3299-3. Epub 2018 Nov 29.
6
Novel Homozygous Nonsense Mutation in the Gene in Two Siblings with Osteoporosis-pseudoglioma Syndrome.两个骨质疏松-假瘤综合征同胞中存在基因的新型纯合无义突变。
J Clin Res Pediatr Endocrinol. 2023 Aug 23;15(3):318-323. doi: 10.4274/jcrpe.galenos.2021.2021.0186. Epub 2021 Dec 30.
7
Osteoporosis-pseudoglioma syndrome: description of 9 new cases and beneficial response to bisphosphonates.骨质疏松-假性胶质瘤综合征:9例新病例描述及对双膦酸盐的有益反应
Bone. 2008 Sep;43(3):584-90. doi: 10.1016/j.bone.2008.04.020. Epub 2008 May 7.
8
Clinical features, treatment, and follow-up of OPPG and high-bone-mass disorders: LRP5 is a key regulator of bone mass.OPPG 和高骨量疾病的临床特征、治疗和随访:LRP5 是骨量的关键调节因子。
Osteoporos Int. 2024 Aug;35(8):1395-1406. doi: 10.1007/s00198-024-07080-x. Epub 2024 Apr 16.
9
Atypical femoral fracture in osteoporosis pseudoglioma syndrome associated with two novel compound heterozygous mutations in LRP5.骨质疏松假性胶质瘤综合征中的非典型股骨骨折与LRP5基因的两个新型复合杂合突变相关。
J Bone Miner Res. 2015 Apr;30(4):615-20. doi: 10.1002/jbmr.2403.
10
Three years follow-up of pamidronate therapy in two brothers with osteoporosis-pseudoglioma syndrome (OPPG) carrying an LRP5 mutation.对两名携带LRP5突变的骨质疏松-假性神经胶质瘤综合征(OPPG)兄弟进行帕米膦酸治疗的三年随访。
J Pediatr Endocrinol Metab. 2008 Aug;21(8):811-8. doi: 10.1515/jpem.2008.21.8.811.

引用本文的文献

1
Osteoporosis and Bone Fragility in Children: Diagnostic and Treatment Strategies.儿童骨质疏松症与骨脆性:诊断与治疗策略
J Clin Med. 2024 Aug 22;13(16):4951. doi: 10.3390/jcm13164951.
2
LRP5, Bone Mass Polymorphisms and Skeletal Disorders.LRP5、骨量多态性与骨骼疾病。
Genes (Basel). 2023 Sep 23;14(10):1846. doi: 10.3390/genes14101846.
3
Clinical Response to Treatment with Teriparatide in an Adolescent with Osteoporosis-Pseudoglioma Syndrome (OPPG): A Case Report.一名患有骨质疏松-假性胶质瘤综合征(OPPG)的青少年对特立帕肽治疗的临床反应:病例报告

本文引用的文献

1
Atypical femoral fracture in osteoporosis pseudoglioma syndrome associated with two novel compound heterozygous mutations in LRP5.骨质疏松假性胶质瘤综合征中的非典型股骨骨折与LRP5基因的两个新型复合杂合突变相关。
J Bone Miner Res. 2015 Apr;30(4):615-20. doi: 10.1002/jbmr.2403.
2
Association of LRP5 genotypes with osteoporosis in Tunisian post-menopausal women.突尼斯绝经后女性中LRP5基因分型与骨质疏松症的关联
BMC Musculoskelet Disord. 2014 Apr 30;15:144. doi: 10.1186/1471-2474-15-144.
3
LRP5 and bone mass regulation: Where are we now?低密度脂蛋白受体相关蛋白5(LRP5)与骨量调节:我们目前的进展如何?
Int J Endocrinol Metab. 2022 Apr 27;20(2):e121031. doi: 10.5812/ijem-121031. eCollection 2022 Apr.
4
Emerging insights into the comparative effectiveness of anabolic therapies for osteoporosis.骨质疏松症中合成代谢治疗的比较效果的新见解。
Nat Rev Endocrinol. 2021 Jan;17(1):31-46. doi: 10.1038/s41574-020-00426-5. Epub 2020 Nov 4.
5
Pathway Mutations in Breast Cancer Using Whole-Exome Sequencing.使用全外显子组测序检测乳腺癌中的通路突变。
Oncol Res. 2020 Mar 27;28(2):107-116. doi: 10.3727/096504019X15698362825407. Epub 2019 Oct 1.
6
BMP4 mutations in tooth agenesis and low bone mass.BMP4 突变与牙齿缺失和低骨量。
Arch Oral Biol. 2019 Jul;103:40-46. doi: 10.1016/j.archoralbio.2019.05.012. Epub 2019 May 15.
7
Sclerostin neutralization unleashes the osteoanabolic effects of Dkk1 inhibition.骨硬化蛋白中和释放 Dkk1 抑制的成骨作用。
JCI Insight. 2018 Jun 7;3(11). doi: 10.1172/jci.insight.98673.
Bonekey Rep. 2012 Jan 10;1:1. doi: 10.1038/bonekey.2012.1. eCollection 2012.
4
Novel mutations affecting LRP5 splicing in patients with osteoporosis-pseudoglioma syndrome (OPPG).影响骨质疏松-假性脑肿瘤综合征(OPPG)患者 LRP5 剪接的新型突变。
Eur J Hum Genet. 2011 Aug;19(8):875-81. doi: 10.1038/ejhg.2011.42. Epub 2011 Mar 16.
5
Novel LRP5 gene mutation in a patient with osteoporosis-pseudoglioma syndrome.患者骨质疏松-假性脑肿瘤综合征中存在 LRP5 基因突变。
Joint Bone Spine. 2010 Mar;77(2):151-3. doi: 10.1016/j.jbspin.2009.11.013. Epub 2010 Jan 21.
6
Osteoporosis-pseudoglioma syndrome: description of 9 new cases and beneficial response to bisphosphonates.骨质疏松-假性胶质瘤综合征:9例新病例描述及对双膦酸盐的有益反应
Bone. 2008 Sep;43(3):584-90. doi: 10.1016/j.bone.2008.04.020. Epub 2008 May 7.
7
The effect of LRP5 polymorphisms on bone mineral density is apparent in childhood.LRP5基因多态性对骨密度的影响在儿童期就很明显。
Calcif Tissue Int. 2007 Jul;81(1):1-9. doi: 10.1007/s00223-007-9024-2. Epub 2007 May 16.
8
A novel mutation in the LRP5 gene is associated with osteoporosis-pseudoglioma syndrome.LRP5基因中的一种新型突变与骨质疏松-假性神经胶质瘤综合征相关。
Osteoporos Int. 2007 Jul;18(7):1017-8. doi: 10.1007/s00198-007-0360-x. Epub 2007 Apr 17.
9
The genetics of low-density lipoprotein receptor-related protein 5 in bone: a story of extremes.骨骼中低密度脂蛋白受体相关蛋白5的遗传学:一个关于极端情况的故事。
Endocrinology. 2007 Jun;148(6):2622-9. doi: 10.1210/en.2006-1352. Epub 2007 Mar 29.
10
Targeting the Wnt/beta-catenin pathway to regulate bone formation in the adult skeleton.靶向Wnt/β-连环蛋白信号通路以调控成年骨骼中的骨形成。
Endocrinology. 2007 Jun;148(6):2635-43. doi: 10.1210/en.2007-0270. Epub 2007 Mar 29.